One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...

DexCom, Inc. (DXCM) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 1:05 PM ESTCompany ParticipantsJereme Sylvain - Executive ...

The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

Leach succeeds Abbott EVP of Diabetes Care, Chris Scoggins, in the position. Eric Benjamin, Insulet’s EVP and COO, will serve as the vice chair for the medical device industry association’s Diabetes ...

Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its ...

The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.

With a market cap of $26.6 billion, DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems for diabetes and metabolic ...

The "Glucose Goddess" built a brand around her blood sugar balancing hacks. She said a few swaps to her diet boosted her mood ...

The S&P 500 closed barely higher Feb. 13, with technology and communications services down on nagging fears of AI-disruption but equities drew support from optimism that cooling ...

The workflow-native platform brings total funding to $40 million as leading firms adopt its end-to-end infrastructure for ...

NYC- and Paris-based DeepIP reaches $40M in total funding, with tenfold ARR growth in 18 months, as workflow-native AI becomes the standard for modern patent operations. $25M Series B co-led by tech ...

For assistance with an IEEE online service or product, please complete the Customer Technical Support form below. For assistance with your IEEE Account, logging into your account and other assistance, ...